Tirzepatide is the active ingredient in the company's highly popular weight loss injection Zepbound and diabetes drug Mounjaro. Eli Lilly's highly popular weight loss drug reduced the risk of ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.

Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...

Pharmaceutical giant Eli Lilly said last week that it will raise the U.K. list price of its weight-loss treatment Mounjaro by ...

Eli Lilly is one of the top growing stocks at the moment. Learn the reasons why this might be a stock to consider.

Eli Lilly's recent performance showcases a robust recovery, driven by impressive sales of its obesity drugs, Mounjaro and ...

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

The company says broad tariffs would raise costs, limit patient access and undermine domestic manufacturing. Eli Lilly is sounding a warning on proposed tariffs on pharmaceuticals, saying it would ...

Novo Nordisk announced Monday that U.S. patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for ...

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official ...

Eli Lilly, a global leader in pharmaceuticals, recently faced a significant share price drop. Last week, the company’s stock ...